Medtronic Comes Under Fire for Flawed Study


Doctor's hired to study the safety of Medtronic's Infuse Bone Graft found to have significant financial ties to the company, calling into question the safety of the product. Medtronic is now paying $2.5 million to an independent researcher to determine whether the product is safe for the public.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Health Updates